MAXHEALTH.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 13:00):

Stats
Šios dienos apimtis	804 100
Vidutinė apimtis	3.20M
Rinkos kapitalizacija	780.64B
EPS	INR0 ( 2024-01-30 )
Kita pelno data	( INR0 ) 2024-05-13
Last Dividend	INR1.000 ( 2023-09-08 )
Next Dividend	INR0 ( N/A )
P/E	74.03
ATR14	INR0.798 (0.10%)

Tūris Koreliacija

Ilgas: -0.24 (neutral)

Trumpas: -0.89 (strong negative)

Signal:(25.541) Be Aware. Possible trading coming up! (swing)

Max Healthcare Institute Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Max Healthcare Institute Koreliacija - Valiuta/Žaliavos

-0.66
( moderate negative )

-0.75
( moderate negative )

0.76
( moderate )

-0.61
( weak negative )

-0.26
( neutral )

-0.32
( neutral )

Max Healthcare Institute Finansinės ataskaitos

Annual	2022
Pajamos:	INR45.63B
Bruto pelnas:	INR36.41B (79.79 %)
EPS:	INR11.38

FY	2022
Pajamos:	INR45.63B
Bruto pelnas:	INR36.41B (79.79 %)
EPS:	INR11.38

FY	2022
Pajamos:	INR38.83B
Bruto pelnas:	INR29.60B (76.23 %)
EPS:	INR6.25

FY	2021
Pajamos:	INR24.82B
Bruto pelnas:	INR18.88B (76.06 %)
EPS:	INR-1.590

Financial Reports:

No articles found.

Max Healthcare Institute Dividends

(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR1.000 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Max Healthcare Institute Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.11 - low (36.69%) | Divividend Growth Potential Score: 3.85 - Decrease likely (23.03%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.000	2023-09-08
Last Dividend	INR1.000	2023-09-08
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	INR1.000	--
Avg. Dividend % Per Year	0.07%	--
Score	1.23	--
Div. Sustainability Score	4.11
Div.Growth Potential Score	3.85
Div. Directional Score	3.98	--

Next Divdend (Est)
(2024-04-28)

INR2.00 Estimate 2.50 %

Dividend Stability

0.20 Very Poor

Dividend Score

1.23

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2023	INR1.000	0.22%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SBIN.NS	Dividend Junior	2023-05-31	Sporadic	29	0.99%
MAHSEAMLES.NS	Dividend Junior	2023-08-14	Annually	21	0.80%
GODFRYPHLP.NS	Dividend Junior	2023-08-11	Annually	24	1.52%
AURIONPRO.NS	Dividend Junior	2023-09-22	Sporadic	19	0.36%
TOUCHWOOD.NS	Dividend Junior	2023-09-22	Annually	6	0.15%
PGIL.NS	Dividend Junior	2023-09-01	Annually	17	1.08%
JINDALSAW.NS	Dividend Junior	2023-06-13	Annually	22	1.62%
DEEPAKNTR.NS	Dividend Junior	2023-07-27	Annually	14	0.25%
SKMEGGPROD.NS	Dividend Junior	2023-08-30	Sporadic	21	0.95%
MGEL.NS	Dividend Junior	2023-08-08	Annually	5	0.59%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.203	1.500	5.94	8.90	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.139	1.500	9.57	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	22.96	1.000	2.61	2.61	[3 - 30]
operatingCashFlowPerShareTTM	3.95	2.00	8.68	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.95	2.00	8.03	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.833	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.259	1.000	6.82	6.82	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.11

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	73.85	1.000	2.64	0	[1 - 100]
returnOnEquityTTM	0.139	2.50	9.72	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.95	2.00	8.68	10.00	[0 - 30]
dividendYielPercentageTTM	0.125	1.500	6.89	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.95	2.00	8.68	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.150	1.500	-2.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0738	1.000	-0.656	0	[0.1 - 0.5]
Total Score				3.85

Max Healthcare Institute

Max Healthcare Institute Limited provides healthcare services in India. It offers services in various specialties, including cancer care/oncology, cardiac sciences, neuro sciences, liver transplant and biliary sciences, orthopaedics, nephrology, kidney transplant, bone marrow transplant, bariatric/weight loss surgery, minimal access/laparoscopic surgery, urology, gastroenterology, and aesthetic and reconstructive surgery. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. As of August 27, 2021, it operated a network of 17 healthcare facilities, including tertiary and quaternary care hospitals at Saket, Patparganj, Vaishali, Rajendra Place, and Shalimar Bagh in Delhi National Capital Region; one each in Mumbai, Mohali, Bathinda, and Dehradun; a secondary care hospital in Gurugram; and day care centres at Noida, Lajpat Nagar, and Panchsheel Park in Delhi National Capital Region and one in Mohali, Punjab. The company is based in Gurugram, India.